According to the survey, in recent years, the incidence of metabolic syndrome diseases such as hyperlipidemia, hyperglycemia and hyperuricemia has been increasing year by year, and the resulting cardiovascular and cerebrovascular diseases have become the main culprits that seriously threaten the lives of the middle-aged and the elderly. At present, the main treatment for lipid-lowering is oral statin drugs. And statin drugs to lower lipids had caused the takeers of rhabdomyolysis evidence-based medical reports and the recent United States Pfizer’s new lipid-lowering drugs in the clinical trial period that led to the takeers of the 82 deaths of the report, so that the patients taking lipid-lowering drugs to fear, so that the doctors are on tenterhooks. Because the vast majority of drugs will not only cause liver damage or cause gallstones, but more importantly, it is difficult to predict what the long-term consequences will be. In short, it is the consensus of many patients and doctors that lipid-lowering drugs should not be used casually. For the treatment of gout caused by high uric acid is also oral allopurinol-based drugs, this kind of drug side effects, patient tolerance is poor. They can cause allopurinol hypersensitivity syndrome, which is particularly common in patients with renal insufficiency and is characterized by skin reactions, fever, eosinophilia, and multi-organ involvement. There is an urgent need to find a safe, low-cost lipid-lowering and uric acid-lowering therapeutic measures. High-pressure ozone therapy has been clinically applied in foreign countries for decades, and has been introduced into our country for nearly ten years. From the feedback information of clinical application at home and abroad, it can see good prospects in internal, external, gynecological, pediatrics and infectious diseases. The treatment technology in anti-inflammatory and anti-infection, analgesia, oxidative degradation of cholesterol and other harmful lipids, oxidative degradation of uric acid and body metabolism of waste products and bacteria and viruses produce poisons and other aspects of the treatment have an ideal effect, to improve the patients and the subhealthy people’s immunity, the treatment of hypoxic diseases also has an obvious role. Research shows that high pressure ozone macroautohemotherapy is the core of high pressure ozone therapy technology, which can make ozone give full play to the medical function of ozone in the 20 minutes before decay. Using ozone can break the Δ5-6 double bond in cholesterol and oxidize it into 4b-2.4DD dinitrophenylhydrazone, so as to achieve the purpose of lowering blood lipids. Clinical applications in other hospitals at home and abroad have confirmed that after 10-15 times of ozone autohemotherapy, about 90% of the blood lipids are significantly improved and about 60% of them are restored to normal. This is the therapeutic effect achieved under the circumstance of not using drugs to lower lipids at all. Clinical reports on the application of high-pressure ozone from the blood treatment of high blood lipids, high blood thickening, cerebrovascular blood supply shortage, stroke, angina pectoris, arrhythmia, myocarditis, vasculitis and so on have ideal therapeutic effect. It is reported in foreign literature that more than 40,000 patients who have received ozone autohemotherapy have been investigated retrospectively, and it is found that only 0.000007% of the patients have had minor side effects, including facial flushing, peripheral heating, dry eyes, generalized fatigue, and these symptoms will disappear soon after the treatment. There have been more than 100,000 times of large autologous blood treatment in China, without a single case of death or serious complications. Compared with drug lipid lowering, ozone therapy has low cost, small side effects, good safety and equally remarkable effect. Therefore, high pressure ozone therapy is called “green therapy”.